Related Experiment Videos
p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review
Anita Koushik1, Robert W Platt, Eduardo L Franco
1Department of Epidemiology and Biostatistics, McGill University, Montréal, Québec, Canada.
Summary
The p53 gene codon 72 polymorphism (Arg/Arg genotype) shows no clear link to cervical neoplasia risk. Methodological issues, particularly Hardy-Weinberg equilibrium in controls, explain inconsistent findings in invasive cervical cancer studies.
Area of Science:
- Molecular biology
- Genetics
- Oncology
- Epidemiology
Background:
- The p53 gene codon 72 polymorphism (Arg/Arg genotype) has been investigated as a potential risk marker for cervical neoplasia.
- Previous research on this association has yielded controversial and heterogeneous results, necessitating a comprehensive review.
- Understanding the role of this genetic variation in cervical cancer pathogenesis is crucial for risk assessment and prevention strategies.
Purpose of the Study:
- To systematically summarize the association between the p53 gene codon 72 polymorphism and cervical neoplasia risk.
- To identify methodological factors contributing to the observed heterogeneity in previous studies.
- To provide a clearer understanding of the p53 codon 72 polymorphism's role in cervical carcinogenesis.
Main Methods:
- A systematic literature review was conducted, identifying 50 articles published between 1998 and 2002.
- Forty-five articles were included in a meta-analysis using random-effects models to combine study-specific odds ratios (ORs).
- Meta-regression analysis was employed to identify methodological features associated with heterogeneity in the results.
Main Results:
- No significant association or heterogeneity was found for preinvasive cervical lesions.
- For invasive cervical cancer of undefined histology, the Arg/Arg genotype did not significantly affect risk (OR, 1.1; 95% CI, 0.9-1.3).
- A slightly increased risk was observed for squamous cell carcinoma (OR, 1.5; 95% CI, 1.2-1.9) and adenocarcinoma (OR, 1.7; 95% CI, 1.0-2.7).
- Departures from Hardy-Weinberg equilibrium in control groups were identified as the primary source of heterogeneity for invasive lesions.
- Meta-analysis of studies in equilibrium yielded null results, suggesting methodological artifacts may explain prior associations.
Conclusions:
- The p53 codon 72 polymorphism may play a role in the late stages of cervical cancer development, but its contribution is likely influenced by methodological factors.
- Heterogeneity in study results, particularly concerning departures from Hardy-Weinberg equilibrium, complicates the assessment of this polymorphism's risk.
- Future research should prioritize rigorous study design and methodological control to accurately evaluate the p53 codon 72 polymorphism's role in cervical cancer.